Oncotelic Therapeutics subsidiary Sapu Nano to present its Deciparticle nanomedicine platform and clinical pipeline at BIO-Europe Spring 2026, seeking partnershipsOncotelic Therapeutics subsidiary Sapu Nano to present its Deciparticle nanomedicine platform and clinical pipeline at BIO-Europe Spring 2026, seeking partnerships

Oncotelic’s Sapu Nano to Showcase Deciparticle Nanomedicine Platform at BIO-Europe Spring 2026

2026/03/24 21:35
2 min read
For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com

Oncotelic Therapeutics, Inc. (OTCQB: OTLC) announced that its subsidiary Sapu Nano will present its Deciparticle nanomedicine platform and clinical pipeline at BIO-Europe Spring 2026 on March 25, where it has been selected as a presenting company. The presentation will highlight the company’s next-generation drug delivery technology designed to improve therapeutic outcomes in oncology.

The company will showcase two lead candidates during the event. Sapu003 (Everolimus for Injection) is currently in Phase 1 clinical trials, while Sapu006 (Docetaxel for Injection) is entering Phase 1 studies. These developments represent significant steps in advancing nanomedicine applications for cancer treatment.

Oncotelic’s participation in BIO-Europe Spring 2026 comes as the company seeks strategic partnerships to advance development and commercialization of its technologies. The event serves as a platform for biotechnology companies to connect with potential partners and investors in the life sciences sector.

The company’s focus on improving drug delivery through nanotechnology has implications for enhancing therapeutic index and unlocking new clinical potential for established cancer treatments. This approach could potentially address limitations in current drug delivery methods and improve patient outcomes in oncology.

For investors seeking additional information about Oncotelic Therapeutics, the company maintains a newsroom at https://ibn.fm/OTLC where updates are regularly posted. The full press release announcing the BIO-Europe Spring 2026 presentation is available at https://ibn.fm/Slq47.

The presentation at BIO-Europe Spring 2026 represents an important opportunity for Oncotelic to demonstrate the potential of its Deciparticle platform to the international biotechnology community. As the company advances its clinical pipeline, this visibility could facilitate partnerships necessary for further development and eventual commercialization of its nanomedicine technologies.

Blockchain Registration, Verification & Enhancement provided by NewsRamp™

This news story relied on content distributed by InvestorBrandNetwork (IBN). Blockchain Registration, Verification & Enhancement provided by NewsRamp™. The source URL for this press release is Oncotelic’s Sapu Nano to Showcase Deciparticle Nanomedicine Platform at BIO-Europe Spring 2026.

The post Oncotelic’s Sapu Nano to Showcase Deciparticle Nanomedicine Platform at BIO-Europe Spring 2026 appeared first on citybuzz.

Market Opportunity
BIO Protocol Logo
BIO Protocol Price(BIO)
$0.01797
$0.01797$0.01797
-1.31%
USD
BIO Protocol (BIO) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

What Happens to Bitcoin If US Bond Yields Soar Above 5%?

What Happens to Bitcoin If US Bond Yields Soar Above 5%?

The post What Happens to Bitcoin If US Bond Yields Soar Above 5%? appeared on BitcoinEthereumNews.com. Bitcoin (BTC) has been among the best-performing assets amid
Share
BitcoinEthereumNews2026/03/25 00:09
China Blocks Nvidia’s RTX Pro 6000D as Local Chips Rise

China Blocks Nvidia’s RTX Pro 6000D as Local Chips Rise

The post China Blocks Nvidia’s RTX Pro 6000D as Local Chips Rise appeared on BitcoinEthereumNews.com. China Blocks Nvidia’s RTX Pro 6000D as Local Chips Rise China’s internet regulator has ordered the country’s biggest technology firms, including Alibaba and ByteDance, to stop purchasing Nvidia’s RTX Pro 6000D GPUs. According to the Financial Times, the move shuts down the last major channel for mass supplies of American chips to the Chinese market. Why Beijing Halted Nvidia Purchases Chinese companies had planned to buy tens of thousands of RTX Pro 6000D accelerators and had already begun testing them in servers. But regulators intervened, halting the purchases and signaling stricter controls than earlier measures placed on Nvidia’s H20 chip. Image: Nvidia An audit compared Huawei and Cambricon processors, along with chips developed by Alibaba and Baidu, against Nvidia’s export-approved products. Regulators concluded that Chinese chips had reached performance levels comparable to the restricted U.S. models. This assessment pushed authorities to advise firms to rely more heavily on domestic processors, further tightening Nvidia’s already limited position in China. China’s Drive Toward Tech Independence The decision highlights Beijing’s focus on import substitution — developing self-sufficient chip production to reduce reliance on U.S. supplies. “The signal is now clear: all attention is focused on building a domestic ecosystem,” said a representative of a leading Chinese tech company. Nvidia had unveiled the RTX Pro 6000D in July 2025 during CEO Jensen Huang’s visit to Beijing, in an attempt to keep a foothold in China after Washington restricted exports of its most advanced chips. But momentum is shifting. Industry sources told the Financial Times that Chinese manufacturers plan to triple AI chip production next year to meet growing demand. They believe “domestic supply will now be sufficient without Nvidia.” What It Means for the Future With Huawei, Cambricon, Alibaba, and Baidu stepping up, China is positioning itself for long-term technological independence. Nvidia, meanwhile, faces…
Share
BitcoinEthereumNews2025/09/18 01:37
‘Clarity once and for all’ – White House reviews SEC’s new crypto framework

‘Clarity once and for all’ – White House reviews SEC’s new crypto framework

The post ‘Clarity once and for all’ – White House reviews SEC’s new crypto framework appeared on BitcoinEthereumNews.com. The U.S. Securities and Exchange Commission
Share
BitcoinEthereumNews2026/03/25 00:30